Nuformix plc (LON: NFX) has appointed Tim Metcalfe as Non-Executive Chairman, with the role taking effect from 1 September 2026.
Nuformix Reports Positive NXP002 Inhalation Study Results
Nuformix plc (LON: NFX) has reported positive preclinical results for NXP002, its potential inhaled treatment for idiopathic pulmonary fibrosis and other progressive fibrosing lung diseases.
Nuformix PLC (LON:NFX) CEO Dr Dan Gooding Interview
The Cambridge-based pharmaceutical development company, Nuformix, were in the studio today to discuss their innovative cocrystal technology and their recent round of fundraising which brought in £1.3 million.